Guyana
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Guyana (GY)
2000 | 16.0 thousand |
2011 | 65.6 thousand |
2024 | 75.7 thousand |
2050 | 101.2 thousand |
Guyana is one of the 22 countries and territories in the IDF North America and Caribbean Region. Guyana has the second highest diabetes prevalence (20-79 years) in the Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS Guyana 2016
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 16.0 | 65.6 | 75.7 | 101.2 |
Age-standardised prevalence of diabetes, % | - | 16.7 | 16.4 | 17.9 |
Proportion of people with undiagnosed diabetes, % | - | - | 36.0 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 27.2 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 19.2 | 23.7 |
Age-standardised prevalence of IFG, % | - | - | 4.0 | 4.0 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 43.2 | 25.7 | 34.2 |
Age-standardised prevalence of IGT, % | - | 11.0 | 5.6 | 6.1 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 1,260.0 | 1,072.5 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 23.0 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 27.3 | 30.0 |
Total diabetes-related health expenditure, ID million | - | - | 47.4 | 52.1 |
Diabetes-related health expenditure per person, USD | - | 165.0 | 360.6 | 296.9 |
Diabetes-related health expenditure per person, ID | - | - | 625.8 | 515.2 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 405.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 108.6 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 514.0 | 422.6 | 506.9 | 600.7 |
Population of children and adolescents (0-19 y) | - | - | 314,449.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 16.0 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 514.0 |
Population of children and adolescents (0-19 y) | - |